Committed to excellence in governance.
The ARIAD Board of Directors is a team of experienced, respected business leaders, committed to the highest standards of corporate governance, sound business practices and financial transparency.
Board of directors
Harvey J. Berger, M.D.
Chairman and Chief Executive Officer, ARIAD Pharmaceuticals, Inc.
Jay R. LaMarche
Former Executive Vice President, Chief Financial Officer and Treasurer, ARIAD Pharmaceuticals, Inc.
Athanase Lavidas, Ph.D.
Chairman and Chief Executive Officer, Lavipharm Group
Massimo Radaelli, Ph.D.
Chairman and Chief Executive Officer of Bioakos Pharma
Norbert G. Riedel, Ph.D.
Former Corporate Vice President and Chief Science and Innovation Officer of Baxter International Inc.
Sarah J. Schlesinger, M.D.
Clinical Investigator and Immunologist at The Rockefeller University in New York City
Robert M. Whelan, Jr.
Financial and Business Advisor
Independent Business Advisor